Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

EntoMed closes $17.5mm second round of funding

Executive Summary

EntoMed (developing drugs based on insects' immune response) has closed a $17.5mm (Euro20mm) private placement to lead investor Apax Partners and existing investors CDC Innovation, Oxford BioScience Partners, Atlas Venture, and to new investors Sofinov and Auriga Ventures.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies